Loss of heterozygosity (LOH) at chromosomal loci has been associated with the presence of tumor suppressor genes at the deleted loci. Twenty-six clinically localized, Stage B prostate carcinomas were analyzed for LOH on chromosomes 10 and 17 using microsatellite markers. Two of 26 carcinomas showed
Four separate regions on chromosome 17 show loss of heterozygosity in familial breast carcinomas
✍ Scribed by Annika Lindblom; Lambert Skoog; Tone Ikdahl Andersen; Sam Rotstein; Magnus Nordenskjöld; Catharina Larsson
- Publisher
- Springer
- Year
- 1993
- Tongue
- English
- Weight
- 767 KB
- Volume
- 91
- Category
- Article
- ISSN
- 0340-6717
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Primary breast tumors were tested for loss of heterozygosity (LOH), on chromosome 9p with microsatellite markers restricted to a 28 cM region including the MTSl gene. LOH was found with at least I marker in 38% of the 20 I cases analyzed. A high frequency of deletions was detected at the 9p23-pZI re
Loss of heterozygosity (LOH) on chromosome 17 is a frequent genetic alteration in breast cancer. To assess whether the location of potential tumor suppressor genes is compatible with the LOH pattern in individual tumors, we analyzed allele loss on chromosome 17 in 121 invasive ductal breast carcinom
The most frequent genetic aberration found in transitional cell carcinoma (TCC) of the bladder involves chromosome 9. Loss of heterozygosity (LOH) analyses show deletions of both chromosome 9p and 9q, while in situ hybridization studies suggest a significant percentage of tumours with monosomy 9. To
## Abstract We have constructed a physical map of chromosome band 17p 13, using 29 markers that had been localized to 17p 13 by means of fluorescence in situ hybridization (FISH) and analysis by pulsed‐field gel electrophoresis (PFGE). The map spans nearly 8 Mb of genomic DNA, and the estimated ave